Back to Trades
Grant4
Aurinia Pharmaceuticals Inc.
AUPH
Total Value
$6.0M
Company Information
- Company Name
- Aurinia Pharmaceuticals Inc.
- Ticker Symbol
- AUPH
- CIK
- 0001600620
Insider Information
- Name
- Greenleaf Peter
- Role
- Chief Executive Officer, Director
- Location
- EDMONTON, A0
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0001600620-26-000021
- Form Type
- 4